Professor Armine Sefton, MB BS, MSc, ILTHM, MD, FRCP (Edin), FRCPath
Professor of Clinical Microbiology
Email: firstname.lastname@example.orgTelephone: 020 7882 8167
Armine Sefton qualified from the London Hospital Medical College in 1980 and obtained her MD in 1993. She was appointed as Senior Lecturer in Medical Microbiology in 1992 with an Honorary Consultant contract with Barts and the London NHS Trust. She became Professor of Clinical Microbiology in 2004. She is on the Specialist Medical Register for both Medical Microbiology and Infectious Disease. She has had a long-term interest in teaching and training at both undergraduate and postgraduate level.
Profile Professor Sefton has been course organiser of the MSc in Clinical Microbiology at Barts and the London since 1992. She is also responsible for the Undergraduate “Infection” training in the Medical School.
At a national level she is currently chair of the Microbiology Board of Examiners for the Royal College of Pathologists and also sits on their College Advisory and Training Team in Microbiology, their Speciality Advisory Committee in Microbiology and the Joint Royal College of Physicians /RCPath Joint Training Committee in Infection and Tropical Medicine. In addition to her RCPath work, she sits on the Executive Committee of the Association of Medical Microbiologists, the Council of the Pathology Section of the Royal Society of Medicine, the Life Sciences Taskforce and the UK Advisory Committee for Dangerous Pathogens.
Course Director of MSc in Clinical Microbiology at Barts and the London and co-director of the new Modernising Scientifc Careers Healthcare Science Masters Programme in Infection. Lead teacher in Undergraduate Infection teaching at Barts and the London
Topics for PhD supervision:
- “Translating the expressed proteome of Listeria monocytogenes virulence genes into diagnostic markers for tracing outbreaks “
- "A multi-centre study on antibiotic resistance in North East Italian Intensive Care Units”
Professor Sefton’s research interests include antimicrobials and antimicrobial resistance, translational research and dangerous pathogens.
Reddy S, Rangaiah J, Addiman S, Wareham D, Wilson P, Sefton A. Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005-2010. Travel Med Infect Dis. 2011 May 31. [Epub ahead of print]
Atkins HS, Spencer S, Brew SD, Jenner DC, Sefton AM, MacMillan AP, Brooks TJ, Simpson AJ. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection. Int J Antimicrob Agents. 2010 Jul; 36(1):66-8.
Kenny DJ, Sefton AM, Steward J, Brooks TJ, Simpson AJ, Atkins HS. Efficacy of the quinolones trovafloxacin and grepafloxacin for therapy of experimental tularaemia and plague. Int J Antimicrob Agents. 2009 Nov;34(5):502-3.
Rajakaruna L, Hallas G, Molenaar L, Dare D, Sutton H, Encheva V, Culak R, Innes I, Ball G, Sefton AM, Eydmann M, Kearns AM, Shah HN. High throughput identification of clinical isolates of Staphylococcus aureus using MALDI-TOF-MS of intact cells. Infect Genet Evol. 2009 Jul;9(4):507-13.
Benedetti P, Pellizzer G, Furlan F, Nicolin R, Rassu M, Sefton A. Staphylococcus caprae meningitis following intraspinal device infection. J Med Microbiol. 2008 Jul;57(Pt 7):904-6.
Oxford JS, Lambkin R, Elliot A, Daniels R, Sefton A, Gill D. (2006)Scientific lessons from the first influenza pandemic of the 20th century. Vaccine. Nov 10;24(44-46):6742-6
View all Armine Sefton's Research Publications at: http://www.researchpublications.qmul.ac.uk